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DESCRIPTION OF TOXIN IN TOXOPLASMOSIS*
DAVID WEINMAN AND H. J. KLATCHKO
Toxin formation is such a common characteristic of bacteria as to make
it seem plausible that other groups of micro6rganisms also produce toxins.
Yet in the protozoa, for example, it has not been possible to demonstrate
any producer of potent toxin-this despite energetic search in malaria and
other diseases where various data have strongly suggested the action of a
toxin. Failure to demonstrate toxin may occur because there is no toxin to
demonstrate, and this seems to be the view generally assumed. The
alternative is that the methods have not been suitable.t
It is the purpose of this paper to describe briefly and in a preliminary
way a toxin which develops in vivo in animals infected with Toxoplasma.
Whether this is to be interpreted as evidence for or against the protozoan
nature of Toxoplasma will be discussed elsewhere. For convenience at
present, the toxin will be referred to as "Toxotoxin" and considered a
single substance, it being well understood that the toxin may later prove
to have several components.
The toxoplasma strain utilized is the RH strain of human origin; it was
originally isolated by A. B. Sabin about eight years ago' and was kindly
furnished to the authors by H. A. Feldman. At present it is highly patho-
genic for mice and rabbits, whereas lethal doses for these animals produce
in rats the chronic type of latent infection with pseudocysts in the brain
which has previously been described.'
Infection was maintained by serial mouse passage. The animals were
injected intra-abdominally, and the peritoneal fluid which developed subse-
quently served for passage material. The customary inoculum was 0.1 cc. of
a 10%o dilution in saline of the supernatant obtained after centrifuging for
thirty minutes at 3600 r.p.m. So treated, mice usually survived about five
days, showing a copious ascites at autopsy.
Peritoneal fluid is usually scanty until about forty-eight hours before
death; then it increases quite rapidly and, if the mice are held until mori-
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bund, 3 cc., or at times more, may be harvested from each mouse. The
physical characteristics of the fluid vary considerably; some samples are
viscid and coagulate spontaneously, either immediately or on standing;
others are watery and show little coagulum on boiling.
The toxin is contained in the peritoneal fluid and can most readily be
put in evidence by intravenous injection in mice. The manifestation is un-
mistakable; death invariably results when adequate doses, ranging from
0.1 to 0.5 cc., of whole peritoneal fluid supernate are so injected.
Spectacular rapidity of action is an outstanding characteristic of the
toxin. When a lethal dose is injected intravenously, the animal is usually
dead before it can be removed from the holding apparatus-sometimes
before the needle is out of the vein. This occurs with minimum lethal doses
established to the nearest 0.1 cc.; with a decrement of 0.1 cc. in the
inoculum the animal usually shows no immediate ill effect. Occasional
samples act more slowly and require ten to fifteen minutes to cause death.
In general, if an animal survives for thirty minutes, it does not subsequently
die from the acute effects of the toxin.
Symptoms are hard to follow in the most acute forms; the animal falls to
one side, makes a few spasmodic movements of fore and hind quarters, and
is dead. When the action is slower, the animal drops where deposited; if on
the ventral surface, it will be prone and not raised upon its legs. It is inert,
does not move, although it may respond to stimulation, and just before
death falls to one side and has the kicking movements described. Respira-
tory distress is often a conspicuous symptom in animals which do not die.
In such, breathing may be periodic with six to ten slow inspirations fol-
lowed by a number of very hurried breaths, then the slow inspirations
begin once more, and so on.
Peritoneal fluid harvested from different mice varies in toxicity. The
usual lethal dose lies between 0.1 and 0.5 cc. for a mouse weighing 20 to 25
grams. In general, samples collected from moribund mice when the fluid is
most copious contain less toxin in a unit volume. This direct relation
between total volume and size of lethal dose suggests that the ascitic fluid
collecting in the abdomen during the final forty-eight hours may have a
diluting effect. A single mouse usually furnishes from four to ten lethal
mouse doses by the method described.
The route of inoculation is of prime importance; the data thus far
presented pertain to intravenous inoculations. Intraperitoneal injections of
as many as five lethal intravenous doses are tolerated perfectly by mice. The
rangeofsusceptible normal animals is not yet ready for report. Toxoplasma-
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infected mice tested one to two days before death require approximately
the same dose of toxin for lethal effect as do normal controls, indicating
neither increased susceptibility nor resistance during the acute phase of
the disease.
Toxotoxin is produced in vivo; no answer is available concerning its
production in vitro since the organism has not been grown on cell-free
medium. Whether it is an endotoxin, an exotoxin, or some type of reaction
product between microorganism and host, cannot be answered as yet. There
is no positive evidence suggesting an endotoxin. In numerous experiments
the injection of toxoplasmata, washed in saline and then lysed by freezing
andthawing, has notgiven toxic symptoms. While doses in excess of 6 X 107
intact organisms have not been given, it should be noted that the centrifuged
supernatant from which these organisms were removed was highly toxic.
Furthermore, supernatant toxic fluid stored with organisms has not
changed detectably in titer. These data suggest that if an endotoxin is
present at all in the washed toxoplasmata, it is not highly concentrated and
is probably not the toxotoxin which is the subject of this report. It is
known that washed toxoplasmata contain antigenic material which elicits
a skin reaction in infected persons and animals.' Thus far toxotoxin resem-
bles the toxin(s) formed within the body of animals infected with anthrax
rather than the more usual bacterial toxins.
Toxotoxin is relatively stable. It is not decreased detectably by storage at
room temperature or for twenty days at 50 C. It resists heating to 56° C.
for thirty minutes and immersion in a boiling water bath for a half hour.
Activity is diminished, however, by autoclaving at 15 lbs. pressure (1210
C.) for twenty minutes.
Toxicity is not appreciably reduced by eight minutes of exposure to
bactericidal ultraviolet rays (2537 A, approximate delivered intensity 346
microwatts per cm2*). It has not been detectably altered by incubation with
neutral formalin to a final concentration of 0.1% for four hours at 370 C.,
whereas after one month at 370 C. with formalin to 0.3%o final concentra-
tion, the titer was reduced to about one-half. Sodium sulfadiazine is
effective in the treatment of toxoplasmosis5 but has shown no activity
against the toxin. Mice first injected intra-abdominally with 10 mg. of drug,
then, three hours later, with a minimum lethal dose of toxin previously
incubated for thirty minutes at 370 C. with sodium sulfadiazine to 0.5%o
final concentration, died promptly.
The toxin may be frozen and dried in the frozen state. It is then stable,
* Calculated from manufacturer's data.
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may be stored and, when reconstituted, is fully active. Such a method is one
means of concentration of relatively dilute toxins; the rehydrated powders
closely approximate the calculated lethal doses.
As yet not very much is known about the chemical constitution of
toxotoxin. Activity is completely destroyed by the action of crystalline
trypsin so that it is a protein, or at least contains a trypsin digestible
protein fraction without which activity is nil. The toxin is stable at the pH
of trypsin activity, so that loss of activity is not a pH effect. Dialyzed
against saline in a collodion bag for ninety-four hours, the toxin did not
diffuse out, for the lethal dose of bag contents increased only as the dilution
factor. This indicates that toxicity is not associated with a substance of low
molecular weight.
Studies on the antigenicity of the toxin have not yet been completed.
It seems not impossible that toxotoxin plays some part in the lethal effects
of the disease toxoplasmosis, bears upon the pathology of the disease, and
is concerned in some of the immunological diagnostic tests in use. These
subjects are now under investigation and will be the subject of subsequent
reports.
Conclusions
1. A toxin is produced in animals infected with Toxoplasmita. It has
provisionally been named toxotoxin, cognizance being taken that it may
prove to have more than one component.
2. The toxin develops in vivo and can be obtained several days before
and up to death.
3. It is produced in the peritoneal fluid of infected animals and is lethal
to mice by the intravenous route.
4. Notable characteristics of toxotoxin are its extreme rapidity of action
and its heat stability.
5. All data thus far obtained suggest that it is not an endotoxin.
6. It is probably a protein or else contains a protein fraction without
which activity is lost. Toxicity is not associated with a substance of low
molecular weight.
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